Skip to main content

ADVERTISEMENT

Beau M. Hawkins, MD

Original Contribution
01/04/2012
Abstract: Background. Percutaneous treatment of saphenous vein graft disease is hampered by high rates of periprocedural myocardial infarction (MI). The use of embolic protection devices (EPD) during these interventions is a class IB...
Abstract: Background. Percutaneous treatment of saphenous vein graft disease is hampered by high rates of periprocedural myocardial infarction (MI). The use of embolic protection devices (EPD) during these interventions is a class IB...
Abstract: Background....
01/04/2012
Journal of Invasive Cardiology